×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IMMX – immix biopharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IMMX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/13
01:10 am
immx
Immix Biopharma (NASDAQ:IMMX) was upgraded by analysts at Wall Street Ze
High
Report
Immix Biopharma (NASDAQ:IMMX) was upgraded by analysts at Wall Street Ze
12/11
12:11 am
immx
Immix Biopharma: Thesis Playing Out; Thoughts On Valuation And Competition [Seeking Alpha]
Medium
Report
Immix Biopharma: Thesis Playing Out; Thoughts On Valuation And Competition [Seeking Alpha]
12/9
05:45 pm
immx
Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Medium
Report
Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
12/9
09:11 am
immx
Immix Biopharma (NASDAQ:IMMX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Immix Biopharma (NASDAQ:IMMX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
12/7
06:20 pm
immx
Immix Biopharma Announces Pricing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Medium
Report
Immix Biopharma Announces Pricing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
12/7
06:15 pm
immx
At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
Medium
Report
At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
11/12
09:13 am
immx
Immix Biopharma Appoints Chief Commercial Officer to Drive NXC-201 Launch [Yahoo! Finance]
High
Report
Immix Biopharma Appoints Chief Commercial Officer to Drive NXC-201 Launch [Yahoo! Finance]
11/12
09:00 am
immx
Immix Biopharma appoints Michael Grabow as chief commercial officer to drive NXC-201 launch [Seeking Alpha]
High
Report
Immix Biopharma appoints Michael Grabow as chief commercial officer to drive NXC-201 launch [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/11
08:00 pm
immx
Form 4 Immix Biopharma, Inc. For: Nov 21 Filed by: CHANG NANCY T
Low
Report
Form 4 Immix Biopharma, Inc. For: Nov 21 Filed by: CHANG NANCY T
12/10
06:49 pm
immx
Form 4 Immix Biopharma, Inc. For: Dec 10 Filed by: Rachman Ilya M
Medium
Report
Form 4 Immix Biopharma, Inc. For: Dec 10 Filed by: Rachman Ilya M
12/10
06:47 pm
immx
Form 4 Immix Biopharma, Inc. For: Dec 08 Filed by: Morris Gabriel S
Medium
Report
Form 4 Immix Biopharma, Inc. For: Dec 08 Filed by: Morris Gabriel S
12/8
05:30 pm
immx
Form 8-K Immix Biopharma, Inc. For: Dec 07
Medium
Report
Form 8-K Immix Biopharma, Inc. For: Dec 07
12/8
05:28 pm
immx
Form 424B5 Immix Biopharma, Inc.
Medium
Report
Form 424B5 Immix Biopharma, Inc.
12/8
06:25 am
immx
Form FWP Immix Biopharma, Inc. Filed by: Immix Biopharma, Inc.
Medium
Report
Form FWP Immix Biopharma, Inc. Filed by: Immix Biopharma, Inc.
12/8
06:18 am
immx
Form 8-K Immix Biopharma, Inc. For: Dec 07
Medium
Report
Form 8-K Immix Biopharma, Inc. For: Dec 07
12/2
06:04 am
immx
Form EFFECT Immix Biopharma, Inc.
Low
Report
Form EFFECT Immix Biopharma, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: